• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期帕金森病患者轻度认知障碍的预后:挪威 ParkWest 研究。

Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.

机构信息

The Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway.

出版信息

JAMA Neurol. 2013 May;70(5):580-6. doi: 10.1001/jamaneurol.2013.2110.

DOI:10.1001/jamaneurol.2013.2110
PMID:23529397
Abstract

IMPORTANCE

Mild cognitive impairment (MCI) is common in Parkinson disease (PD), but the prognostic value of MCI in early PD is unknown.

OBJECTIVE

To examine the course of MCI and its progression to dementia in an incident PD cohort.

DESIGN

Prospective longitudinal cohort study.

SETTING

The Norwegian ParkWest study, an ongoing population-based study of the incidence, neurobiology, and prognosis of PD in western and southern Norway.

PARTICIPANTS

A population-based cohort of 182 patients with incident PD monitored for 3 years.

MAIN OUTCOMES AND MEASURES

Serial neuropsychological tests of attention, executive function, verbal memory, and visuospatial skills were administered at baseline, 1 year, and 3 years. Patients were classified as having MCI and received a diagnosis of dementia according to published consensus criteria.

RESULTS

Significantly more patients with MCI than without MCI at baseline (10 of 37 [27.0%] vs 1 of 145 [0.7%]; relative risk, 39.2 [95% CI, 5.2-296.5]; P < .001) progressed to dementia during follow-up. Of those with MCI at baseline, 8 of 37 (21.6%) had MCI that reverted to normal cognition during follow-up. Mild cognitive impairment at the 1-year visit was associated with a similar progression rate to dementia (10 of 36 patients [27.8%]) and reversion rate to normal cognition (7 of 36 [19.4%]). However, among the 22 patients with persistent MCI at baseline and the 1-year visit, 10 (45.5%) developed dementia and only 2 (9.1%) had MCI that reverted to normal cognition by the end of study.

CONCLUSIONS AND RELEVANCE

Mild cognitive impairment at PD diagnosis predicts a highly increased risk for early dementia. Repeated neuropsychological testing increases the prognostic accuracy of MCI with respect to early dementia development in PD.

摘要

重要性

轻度认知障碍(MCI)在帕金森病(PD)中很常见,但 MCI 在早期 PD 中的预后价值尚不清楚。

目的

在一个 PD 新发病例队列中,研究 MCI 的病程及其向痴呆的进展。

设计

前瞻性纵向队列研究。

地点

挪威 ParkWest 研究,这是一项正在进行的、基于人群的研究,旨在研究挪威西部和南部 PD 的发病率、神经生物学和预后。

参与者

182 名 PD 新发病例的人群队列,随访 3 年。

主要结果和测量

在基线、1 年和 3 年时,进行了注意力、执行功能、言语记忆和视空间技能的连续神经心理学测试。根据发表的共识标准,患者被分类为 MCI,并接受痴呆诊断。

结果

与无基线 MCI 的患者相比,基线时有 MCI 的患者显著更多(10/37 [27.0%] vs 1/145 [0.7%];相对风险,39.2 [95%CI,5.2-296.5];P<0.001)在随访期间进展为痴呆。在基线时有 MCI 的患者中,8/37(21.6%)的 MCI 在随访期间恢复为正常认知。在 1 年就诊时的轻度认知障碍与类似的痴呆进展率(36 例患者中的 10 例[27.8%])和恢复为正常认知的比率(36 例患者中的 7 例[19.4%])相关。然而,在基线时和 1 年就诊时持续存在 MCI 的 22 名患者中,10 名(45.5%)发展为痴呆,仅有 2 名(9.1%)的 MCI 在研究结束时恢复为正常认知。

结论和相关性

PD 诊断时的轻度认知障碍预测早期痴呆的风险显著增加。重复的神经心理学测试提高了 MCI 在 PD 早期痴呆发展方面的预后准确性。

相似文献

1
Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.早期帕金森病患者轻度认知障碍的预后:挪威 ParkWest 研究。
JAMA Neurol. 2013 May;70(5):580-6. doi: 10.1001/jamaneurol.2013.2110.
2
Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study.帕金森病轻度认知障碍的自然病程:一项基于人群的5年研究。
Neurology. 2017 Feb 21;88(8):767-774. doi: 10.1212/WNL.0000000000003634. Epub 2017 Jan 20.
3
Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.帕金森病中的轻度认知障碍及其向痴呆症的进展:登比郡队列的16年结局评估。
Int J Geriatr Psychiatry. 2015 Oct;30(10):1048-55. doi: 10.1002/gps.4261. Epub 2015 Feb 11.
4
Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.新发未治疗帕金森病的认知障碍:挪威ParkWest研究
Neurology. 2009 Mar 31;72(13):1121-6. doi: 10.1212/01.wnl.0000338632.00552.cb. Epub 2008 Nov 19.
5
Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.帕金森病中的轻度认知障碍:诊断及向痴呆的进展
J Clin Exp Neuropsychol. 2016;38(1):40-50. doi: 10.1080/13803395.2015.1087465. Epub 2015 Nov 25.
6
Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia.帕金森病伴轻度认知障碍和痴呆患者的认知特征分析。
Parkinsonism Relat Disord. 2014 Apr;20(4):394-9. doi: 10.1016/j.parkreldis.2014.01.009. Epub 2014 Jan 22.
7
Evolution of mild cognitive impairment in Parkinson disease.帕金森病患者轻度认知障碍的演变。
Neurology. 2013 Jul 23;81(4):346-52. doi: 10.1212/WNL.0b013e31829c5c86. Epub 2013 Jun 21.
8
Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.嗅觉功能和神经心理学特征在轻度认知障碍患者中鉴别路易体痴呆与阿尔茨海默病:一项5年随访研究
J Neurol Sci. 2015 Aug 15;355(1-2):174-9. doi: 10.1016/j.jns.2015.06.013. Epub 2015 Jun 10.
9
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study.新诊断帕金森病中的轻度认知障碍:一项纵向前瞻性研究。
Parkinsonism Relat Disord. 2015 Oct;21(10):1219-26. doi: 10.1016/j.parkreldis.2015.08.024. Epub 2015 Aug 21.
10
Mild cognitive impairment and dementia in primary care: the value of medical history.初级保健中的轻度认知障碍和痴呆:病史的价值。
Fam Pract. 2011 Aug;28(4):385-92. doi: 10.1093/fampra/cmr005. Epub 2011 Mar 14.

引用本文的文献

1
Risk factors for mild cognitive impairment in Parkinson disease: a systematic review and meta-analysis.帕金森病轻度认知障碍的危险因素:一项系统评价和荟萃分析。
Mol Cell Biochem. 2025 Sep 18. doi: 10.1007/s11010-025-05392-y.
2
Risk factors and predictors for Lewy body dementia: a systematic review.路易体痴呆的风险因素和预测因素:一项系统综述。
NPJ Dement. 2025;1(1):20. doi: 10.1038/s44400-025-00022-2. Epub 2025 Aug 4.
3
The application of radiomics in the diagnosis and evaluation of cognitive impairment related to neurological diseases.
放射组学在神经疾病相关认知障碍诊断与评估中的应用。
Front Neurosci. 2025 Jul 2;19:1591605. doi: 10.3389/fnins.2025.1591605. eCollection 2025.
4
Cognitive impairment and dementia in Latin American individuals with parkinsonism and Parkinson's disease: A 10/66 Dementia Research Group study.拉丁美洲帕金森综合征和帕金森病患者的认知障碍与痴呆:10/66痴呆研究小组研究
Alzheimers Dement. 2025 Jul;21(7):e70371. doi: 10.1002/alz.70371.
5
Walking reduces the risk of dementia in patients with Parkinson's disease: a longitudinal follow-up study.步行可降低帕金森病患者患痴呆症的风险:一项纵向随访研究。
Ther Adv Neurol Disord. 2025 Apr 12;18:17562864251330251. doi: 10.1177/17562864251330251. eCollection 2025.
6
Fist-Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach.握拳-手掌测试可能识别帕金森病中的轻度认知障碍和步态冻结:一种机器学习方法。
Mov Disord Clin Pract. 2025 Aug;12(8):1105-1112. doi: 10.1002/mdc3.70080. Epub 2025 Apr 19.
7
Cardiovascular health and its association with dementia, Parkinson's Disease, and mortality among UK older adults.英国老年人的心血管健康及其与痴呆症、帕金森病和死亡率的关联。
Brain Behav Immun Health. 2025 Mar 27;45:100986. doi: 10.1016/j.bbih.2025.100986. eCollection 2025 May.
8
Correlation between plasma epidermal growth factor and follow-up cognitive decline in Parkinson's disease.帕金森病患者血浆表皮生长因子与随访认知功能下降的相关性
Neurol Sci. 2025 May;46(5):2129-2135. doi: 10.1007/s10072-025-08014-z. Epub 2025 Feb 10.
9
Diagnostic values of serum levels of α-synuclein, homocysteine and leucine-rich α2 glycoprotein for predicting cognitive impairment in Parkinson's disease.血清α-突触核蛋白、同型半胱氨酸和富含亮氨酸的α2糖蛋白水平对预测帕金森病认知障碍的诊断价值
Acta Neurol Belg. 2025 Apr;125(2):435-444. doi: 10.1007/s13760-024-02710-x. Epub 2024 Dec 30.
10
Air pollution: a latent key driving force of dementia.空气污染:痴呆症的潜在关键驱动因素。
BMC Public Health. 2024 Sep 2;24(1):2370. doi: 10.1186/s12889-024-19918-4.